Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+2.73%)
As of: Oct 2, 2026 · 9:56 AM EDT

Rani Therapeutics Holdings (RANI) Other financing activities (2022 - 2026)

Updated

Rani Therapeutics Holdings' Other financing activities was $9,000 in Q2 2026, up 12.5% from $8,000 a year earlier but down 71.9% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Other financing activities (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Rani Therapeutics Holdings' Other financing activities was $69,000 through Jun 30, 2026, up 27.8% year-over-year; for FY2025, it came in at $59,000, up 25.5% from FY2024.

  • Other financing activities shows a three-year compound annual growth rate of -54.5% (FY2022 to FY2025).
  • In earlier years, Other financing activities was $47,000 in FY2024 (-71.0%), $162,000 in FY2023 (-74.1%) and $626,000 in FY2022.
  • Quarterly Other financing activities has moved between $7,000 (Q3 2025) and $626,000 (Q3 2022) over five years.
  • Compared with a year earlier, Other financing activities has increased for three straight quarters, with growth averaging 2.8% over the last six quarters.
  • The best year-over-year quarter for Other financing activities over five years was Q2 2024 (growth of 166.7%); the worst was Q3 2023 (a decline of 95.4%).
  • Per Business Quant data, RANI's Other financing activities in the three quarters before Q2 2026 was $32,000 (Q1 2026), $21,000 (Q4 2025) and $7,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Mar 31, 2026 32,000.00
Dec 31, 2025 21,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 8,000.00
Mar 31, 2025 23,000.00
Dec 31, 2024 9,000.00
Sep 30, 2024 14,000.00
Jun 30, 2024 24,000.00
Sep 30, 2023 29,000.00
Jun 30, 2023 9,000.00
Mar 31, 2023 124,000.00
Sep 30, 2022 626,000.00
API Access

Rani Therapeutics Holdings Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RANI&period=max&api_key=YOUR_API_KEY